These results support the notion that ANGPTL8 mediates, at least in part, the improvement of NAFLD after bariatric surgery via the improvement of hepatic lipid metabolism. This evidence concerns the gene ANGPTL8 and metabolic dysfunction-associated steatotic liver disease.